Evidence map›Paper›PMID 30377108›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2018

[Value of podocalyxin levels in urinary extracellular vesicles for diagnosis of diabetic nephropathy].

Fan Wu, Yunyin Chen, Hua Xiao, Ziliang Zou, Jing Ning, Haishan Chen, Hequn Zou

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Fan WuDepartment of Nephrology, Affiliated Hospital of Putian University, Putian 351100, China.
Yunyin ChenDepartment of Nephrology, Affiliated Hospital of Putian University, Putian 351100, China.
Hua XiaoDepartment of Nephrology, Affiliated Hospital of Putian University, Putian 351100, China.
Ziliang ZouDepartment of Nephrology, Affiliated Hospital of Putian University, Putian 351100, China.
Jing NingDepartment of Nephrology, Affiliated Hospital of Putian University, Putian 351100, China.
Haishan ChenDepartment of Nephrology, Affiliated Hospital of Putian University, Putian 351100, China.
Hequn ZouDepartment of Nephrology, Affiliated Hospital of Putian University, Putian 351100, China.
Putian University · CNShunde Polytechnic · CNThird Affiliated Hospital of Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the value of detecting podocalyxin (PCX) level in urinary extracellular vesicles for the diagnosis of diabetic nephropathy.

methodsThis study was conducted among 57 diabetic patients admitted during the period from March to September, 2017, including 34 with uncomplicated diabetics and 23 with diabetic nephropathy; 21 patients with other types of nephropathy and 11 healthy individuals were also included to serve as the controls. Transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA) were used to verify the separation of urinary extracellular vesicles. The molecular markers of extracellular vesicles (TSG101 and podocalyxin [PCX]) were detected using Western blotting. PCX levels in extracellular vesicles were also detected using ELISA.

resultsTEM reveal the presence of numerous extracellular vesicles in the urine with intact morphology and different sizes, and most of them were below 300 nm in diameter as shown by NTA. TSG101 expression was detected in the samples from all the 4 groups. Positive expression of PCX was detected in the samples from patients with diabetic nephropathy but not in the other groups. In patients with diabetic nephropathy, the mean PCX levels (3.27±2.30 ng/μmol)was significantly higher than those in the healthy control group (1.22±0.36 ng/μmol), uncomplicated diabetes group (2.22±1.29 ng/μmol) and nephropathy group (1.24±0.45 ng/μmol).

conclusionsPCX level in urinary extracellular vesicles is significantly increased in patients with diabetic nephropathy, suggesting the value of PCX as a potential marker for clinical diagnosis of diabetic nephropathy.

Indexed as

BiomarkersCase-Control StudiesDiabetic NephropathiesDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportExtracellular VesiclesHumansMicroscopy, Electron, TransmissionNanoparticlesSialoglycoproteinsTranscription FactorsTsg101 ProteinBiomarkersDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportpodocalyxinSialoglycoproteinsTranscription FactorsTsg101 Proteindiabetic nephropathyexosomespodocalyxinurinary extracellular vesicles

Identifiers

PMID30377108
PMCPMC6744190
OpenAlexW3010579434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.